Global Drugs of Bioengineered Protein Market Growth, Trends, and Forecasts 2015-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Drugs of Bioengineered Protein will have significant change from previous year. By the most conservative estimates of global Drugs of Bioengineered Protein market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Drugs of Bioengineered Protein market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs of Bioengineered Protein market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Drugs of Bioengineered Protein, covering the supply chain analysis, impact assessment to the Drugs of Bioengineered Protein market size growth rate in several scenarios, and the measures to be undertaken by Drugs of Bioengineered Protein companies in response to the COVID-19 epidemic.
Segmentation by product type:
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Segmentation by Application
Endocrinology
Immunology
Hematology
Infectiology
Neurology
Oncology
Genetic Disorder
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
Rest of Americas
APAC
China
Japan
Korea
Taiwan
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Rest of APAC
Europe
Germany
France
UK
Russia
Italy
Benelux
Nordic
Rest of Europe
MENA
Saudi Arabia
UAE
Turkey
South Africa
Egypt
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.
GlaxoSmithKline
Amgen
Johnson & Johnson
Novartis
Sanofi
Merck
Dr. Reddy's Laboratories
Eli Lilly
Abbott Laboratories
Roche
Bayer AG
Panacea Biotec
Fresenius kabi
Biocon
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Drugs of Bioengineered Protein?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Drugs of Bioengineered Protein Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 Market Overview
2.1.1 Global Drugs of Bioengineered Protein Market Size and Forecast, 2015-2025
2.1.2 Drugs of Bioengineered Protein Market Size and Forecast by Region, 2015 VS 2020 VS 2025
2.2 Global Drugs of Bioengineered Protein Market Size and Forecast by Regions, 2015-2025 ($ millions)
2.3 Americas Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
2.4 APAC Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
2.5 Europe Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
2.6 MENA Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
3 Drugs of Bioengineered Protein Market Size by Player
3.1 Global Drugs of Bioengineered Protein Market Size by Player
3.1.1 Global Top Players Drugs of Bioengineered Protein Revenue, 2018-2020E ($ millions)
3.1.2 Global Top Drugs of Bioengineered Protein Players Market Share, 2018-2020E
3.2 Global Key Drugs of Bioengineered Protein Players Rank in 2019
3.3 Global Key Drugs of Bioengineered Protein Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
3.4.1 Competition Landscape Analysis
3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion
4 Drugs of Bioengineered Protein Segment by Type
4.1 Overview
4.1.1 Monoclonal Antibodies
4.1.2 Therapeutic Proteins
4.1.3 Vaccines
4.2 Global Drugs of Bioengineered Protein Market Size by Type, 2015-2025 ($ millions)
4.3 Monoclonal Antibodies Market Size by Region, 2015-2025 ($ millions)
4.4 Therapeutic Proteins Market Size by Region, 2015-2025 ($ millions)
4.5 Vaccines Market Size by Region, 2015-2025 ($ millions)
5 Drugs of Bioengineered Protein Segment by Application
5.1 Overview
5.1.1 Endocrinology
5.1.2 Immunology
5.1.3 Hematology
5.1.4 Infectiology
5.1.5 Neurology
5.1.6 Oncology
5.1.7 Genetic Disorder
5.2 Global Drugs of Bioengineered Protein Market Size by Application, 2015-2025 ($ millions)
5.3 Endocrinology Market Size by Region, 2015-2025 ($ millions)
5.4 Immunology Market Size by Region, 2015-2025 ($ millions)
5.5 Hematology Market Size by Region, 2015-2025 ($ millions)
5.6 Infectiology Market Size by Region, 2015-2025 ($ millions)
5.7 Neurology Market Size by Region, 2015-2025 ($ millions)
5.8 Oncology Market Size by Region, 2015-2025 ($ millions)
5.9 Genetic Disorder Market Size by Region, 2015-2025 ($ millions)
6 Americas
6.1 Americas Drugs of Bioengineered Protein Market Size by Country
6.2 United States Drugs of Bioengineered Protein Market Size
6.3 Canada Drugs of Bioengineered Protein Market Size
6.4 Mexico Drugs of Bioengineered Protein Market Size
6.5 Brazil Drugs of Bioengineered Protein Market Size
7 APAC
7.1 APAC Drugs of Bioengineered Protein Market Size by Regions
7.2 China Drugs of Bioengineered Protein Market Size
7.3 Japan Drugs of Bioengineered Protein Market Size
7.4 Korea Drugs of Bioengineered Protein Market Size
7.5 Taiwan Drugs of Bioengineered Protein Market Size
7.6 India Drugs of Bioengineered Protein Market Size
7.7 Australia Drugs of Bioengineered Protein Market Size
7.8 Indonesia Drugs of Bioengineered Protein Market Size
7.9 Thailand Drugs of Bioengineered Protein Market Size
7.10 Malaysia Drugs of Bioengineered Protein Market Size
7.11 Philippines Drugs of Bioengineered Protein Market Size
7.12 Vietnam Drugs of Bioengineered Protein Market Size
8 Europe
8.1 Europe Drugs of Bioengineered Protein by Country
8.2 Germany Drugs of Bioengineered Protein Market Size
8.3 France Drugs of Bioengineered Protein Market Size
8.4 UK Drugs of Bioengineered Protein Market Size
8.5 Russia Drugs of Bioengineered Protein Market Size
8.6 Italy Drugs of Bioengineered Protein Market Size
8.7 Australia Drugs of Bioengineered Protein Market Size
8.8 Benelux Drugs of Bioengineered Protein Market Size
8.9 Nordic Drugs of Bioengineered Protein Market Size
9 MENA
9.1 MENA & Africa Drugs of Bioengineered Protein by Country
9.2 Saudi Arabia Drugs of Bioengineered Protein Market Size
9.3 UAE Drugs of Bioengineered Protein Market Size
9.4 Turkey Drugs of Bioengineered Protein Market Size
9.5 South Africa Drugs of Bioengineered Protein Market Size
9.6 Egypt Drugs of Bioengineered Protein Market Size
10 Market Drivers, Challenges and Trends
10.1 Market Drivers and Impact
10.1.1 Growing Demand from Key Regions
10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends
11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Drugs of Bioengineered Protein Product Offered
11.1.3 GlaxoSmithKline Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Drugs of Bioengineered Protein Product Offered
11.2.3 Amgen Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Drugs of Bioengineered Protein Product Offered
11.3.3 Johnson & Johnson Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Drugs of Bioengineered Protein Product Offered
11.4.3 Novartis Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Drugs of Bioengineered Protein Product Offered
11.5.3 Sanofi Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Drugs of Bioengineered Protein Product Offered
11.6.3 Merck Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Information
11.7.2 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product Offered
11.7.3 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.7.4 Dr. Reddy's Laboratories Main Business Overview
11.7.5 Dr. Reddy's Laboratories Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Drugs of Bioengineered Protein Product Offered
11.8.3 Eli Lilly Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Information
11.9.2 Abbott Laboratories Drugs of Bioengineered Protein Product Offered
11.9.3 Abbott Laboratories Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.9.4 Abbott Laboratories Main Business Overview
11.9.5 Abbott Laboratories Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Drugs of Bioengineered Protein Product Offered
11.10.3 Roche Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Drugs of Bioengineered Protein Product Offered
11.11.3 Bayer AG Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.11.4 Bayer AG Main Business Overview
11.11.5 Bayer AG Latest Developments
11.12 Panacea Biotec
11.12.1 Panacea Biotec Company Information
11.12.2 Panacea Biotec Drugs of Bioengineered Protein Product Offered
11.12.3 Panacea Biotec Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.12.4 Panacea Biotec Main Business Overview
11.12.5 Panacea Biotec Latest Developments
11.13 Fresenius kabi
11.13.1 Fresenius kabi Company Information
11.13.2 Fresenius kabi Drugs of Bioengineered Protein Product Offered
11.13.3 Fresenius kabi Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.13.4 Fresenius kabi Main Business Overview
11.13.5 Fresenius kabi Latest Developments
11.14 Biocon
11.14.1 Biocon Company Information
11.14.2 Biocon Drugs of Bioengineered Protein Product Offered
11.14.3 Biocon Drugs of Bioengineered Protein Revenue and YoY Growth, 2018-2020E
11.14.4 Biocon Main Business Overview
11.14.5 Biocon Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Drugs of Bioengineered Protein Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Drugs of Bioengineered Protein Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Drugs of Bioengineered Protein Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Global Drugs of Bioengineered Protein Market Size by Regions, 2015-2025 ($ millions)
Table 7. Global Drugs of Bioengineered Protein Market Size Share by Regions, 2015-2025
Table 8. Global Drugs of Bioengineered Protein Revenue by Player, 2018-2020E ($ millions)
Table 9. Global Drugs of Bioengineered Protein Revenue Market Share by Player, 2018-2020E
Table 10. Global Key Drugs of Bioengineered Protein Players Rank in 2019, Based on the Revenue in Drugs of Bioengineered Protein
Table 11. Global Key Drugs of Bioengineered Protein Players Head office and Products Offered
Table 12. Drugs of Bioengineered Protein Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
Table 13. New Products and Potential Entrants
Table 14. Mergers & Acquisitions, Expansion
Table 15. Major Players of Monoclonal Antibodies
Table 16. Major Players of Therapeutic Proteins
Table 17. Major Players of Vaccines
Table 18. Global Drugs of Bioengineered Protein Market Size CAGR by Type ($ millions): 2015 VS 2020 VS 2025
Table 19. Global Drugs of Bioengineered Protein Market Size by Type, 2015-2025 ($ millions)
Table 20. Global Drugs of Bioengineered Protein Market Size Share by Type, 2015-2025
Table 21. Global Monoclonal Antibodies Market Size by Region, 2015-2025 ($ millions)
Table 22. Global Monoclonal Antibodies Market Size Share by Region, 2015-2025
Table 23. Global Therapeutic Proteins Market Size by Region, 2015-2025 ($ millions)
Table 24. Global Therapeutic Proteins Market Size Share by Region, 2015-2025
Table 25. Global Vaccines Market Size by Region, 2015-2025 ($ millions)
Table 26. Global Vaccines Market Size Share by Region, 2015-2025
Table 27. Global Drugs of Bioengineered Protein Market Size CAGR by Application ($ millions): 2015 VS 2020 VS 2025
Table 28. Global Drugs of Bioengineered Protein Market Size by Application, 2015-2025 ($ millions)
Table 29. Global Drugs of Bioengineered Protein Market Size Share by Application, 2015-2025
Table 30. Global Endocrinology Market Size by Region, 2015-2025 ($ millions)
Table 31. Global Endocrinology Market Size Share by Region, 2015-2025
Table 32. Global Immunology Market Size by Region, 2015-2025 ($ millions)
Table 33. Global Immunology Market Size Share by Region, 2015-2025
Table 34. Global Hematology Market Size by Region, 2015-2025 ($ millions)
Table 35. Global Hematology Market Size Share by Region, 2015-2025
Table 36. Global Infectiology Market Size by Region, 2015-2025 ($ millions)
Table 37. Global Infectiology Market Size Share by Region, 2015-2025
Table 38. Global Neurology Market Size by Region, 2015-2025 ($ millions)
Table 39. Global Neurology Market Size Share by Region, 2015-2025
Table 40. Global Oncology Market Size by Region, 2015-2025 ($ millions)
Table 41. Global Oncology Market Size Share by Region, 2015-2025
Table 42. Global Genetic Disorder Market Size by Region, 2015-2025 ($ millions)
Table 43. Global Genetic Disorder Market Size Share by Region, 2015-2025
Table 44. Americas Drugs of Bioengineered Protein Market Size by Country (2015-2020) ($ Millions)
Table 45. Americas Drugs of Bioengineered Protein Market Size Share by Countries (2015-2020)
Table 46. APAC Drugs of Bioengineered Protein Market Size by Region (2015-2020) ($ Millions)
Table 47. APAC Drugs of Bioengineered Protein Market Size Share by Region (2015-2020)
Table 48. Europe Drugs of Bioengineered Protein Market Size by Country (2015-2020) ($ Millions)
Table 49. Europe Drugs of Bioengineered Protein Market Size Share by Country (2015-2020)
Table 50. MENA Drugs of Bioengineered Protein Market Size by Country (2015-2020) ($ Millions)
Table 51. MENA Drugs of Bioengineered Protein Market Size Share by Country (2015-2020)
Table 52. Key and Potential Regions of Drugs of Bioengineered Protein
Table 53. Key Application and Potential Industries of Drugs of Bioengineered Protein
Table 54. Key Challenges of Drugs of Bioengineered Protein
Table 55. Key Trends of Drugs of Bioengineered Protein
Table 56. GlaxoSmithKline Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 57. GlaxoSmithKline Drugs of Bioengineered Protein Product Offered
Table 58. GlaxoSmithKline Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Latest Developments
Table 61. Amgen Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 62. Amgen Drugs of Bioengineered Protein Product Offered
Table 63. Amgen Main Business
Table 64. Amgen Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 65. Amgen Latest Developments
Table 66. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 67. Johnson & Johnson Drugs of Bioengineered Protein Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 70. Johnson & Johnson Latest Developments
Table 71. Novartis Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 72. Novartis Drugs of Bioengineered Protein Product Offered
Table 73. Novartis Main Business
Table 74. Novartis Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 75. Novartis Latest Developments
Table 76. Sanofi Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 77. Sanofi Drugs of Bioengineered Protein Product Offered
Table 78. Sanofi Main Business
Table 79. Sanofi Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 80. Sanofi Latest Developments
Table 81. Merck Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 82. Merck Drugs of Bioengineered Protein Product Offered
Table 83. Merck Main Business
Table 84. Merck Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 85. Merck Latest Developments
Table 86. Dr. Reddy's Laboratories Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 87. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product Offered
Table 88. Dr. Reddy's Laboratories Main Business
Table 89. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 90. Dr. Reddy's Laboratories Latest Developments
Table 91. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 92. Eli Lilly Drugs of Bioengineered Protein Product Offered
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 95. Eli Lilly Latest Developments
Table 96. Abbott Laboratories Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 97. Abbott Laboratories Drugs of Bioengineered Protein Product Offered
Table 98. Abbott Laboratories Main Business
Table 99. Abbott Laboratories Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 100. Abbott Laboratories Latest Developments
Table 101. Roche Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 102. Roche Drugs of Bioengineered Protein Product Offered
Table 103. Roche Main Business
Table 104. Roche Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 105. Roche Latest Developments
Table 106. Bayer AG Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 107. Bayer AG Drugs of Bioengineered Protein Product Offered
Table 108. Bayer AG Main Business
Table 109. Bayer AG Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 110. Bayer AG Latest Developments
Table 111. Panacea Biotec Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 112. Panacea Biotec Drugs of Bioengineered Protein Product Offered
Table 113. Panacea Biotec Main Business
Table 114. Panacea Biotec Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 115. Panacea Biotec Latest Developments
Table 116. Fresenius kabi Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 117. Fresenius kabi Drugs of Bioengineered Protein Product Offered
Table 118. Fresenius kabi Main Business
Table 119. Fresenius kabi Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 120. Fresenius kabi Latest Developments
Table 121. Biocon Details, Company Total Revenue (in $ million), Head Office, Drugs of Bioengineered Protein Major Market Areas and Its Competitors
Table 122. Biocon Drugs of Bioengineered Protein Product Offered
Table 123. Biocon Main Business
Table 124. Biocon Drugs of Bioengineered Protein Revenue ($ million) and YoY Growth, 2018-2020E
Table 125. Biocon Latest Developments
List of Figures
Figure 1. Drugs of Bioengineered Protein Report Years Considered
Figure 2. Global Drugs of Bioengineered Protein Market Size Growth Rate, 2015-2025 ($ millions)
Figure 3. Drugs of Bioengineered Protein Consumption by Region (2015 VS 2020 & 2025) ($ millions)
Figure 4. Global Drugs of Bioengineered Protein Market Size Share by Regions, 2015-2025
Figure 5. Americas Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 6. APAC Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 7. Europe Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 8. MENA Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 9. Global Drugs of Bioengineered Protein Revenue Market Share by Player in 2019
Figure 10. Global Drugs of Bioengineered Protein Market Size Share by Type in 2019
Figure 11. Drugs of Bioengineered Protein in Endocrinology
Figure 12. Global Drugs of Bioengineered Protein Market Size YoY Growth: Endocrinology, 2015-2025 ($ millions)
Figure 13. Drugs of Bioengineered Protein in Immunology
Figure 14. Global Drugs of Bioengineered Protein Market Size YoY Growth: Immunology, 2015-2025 ($ millions)
Figure 15. Drugs of Bioengineered Protein in Hematology
Figure 16. Global Drugs of Bioengineered Protein Market Size YoY Growth: Hematology, 2015-2025 ($ millions)
Figure 17. Drugs of Bioengineered Protein in Infectiology
Figure 18. Global Drugs of Bioengineered Protein Market Size YoY Growth: Infectiology, 2015-2025 ($ millions)
Figure 19. Drugs of Bioengineered Protein in Neurology
Figure 20. Global Drugs of Bioengineered Protein Market Size YoY Growth: Neurology, 2015-2025 ($ millions)
Figure 21. Drugs of Bioengineered Protein in Oncology
Figure 22. Global Drugs of Bioengineered Protein Market Size YoY Growth: Oncology, 2015-2025 ($ millions)
Figure 23. Drugs of Bioengineered Protein in Genetic Disorder
Figure 24. Global Drugs of Bioengineered Protein Market Size YoY Growth: Genetic Disorder, 2015-2025 ($ millions)
Figure 25. Americas Drugs of Bioengineered Protein Value Market Share by Country in 2019
Figure 26. United States Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 27. Canada Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 28. Mexico Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 29. Brazil Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 30. APAC Drugs of Bioengineered Protein Value Market Share by Region in 2019
Figure 31. China Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 32. Japan Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 33. Korea Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 34. Taiwan Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 35. India Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 36. Australia Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 37. Indonesia Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 38. Thailand Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 39. Malaysia Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 40. Philippines Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 41. Vietnam Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 42. Europe Drugs of Bioengineered Protein Value Market Share by Country in 2019
Figure 43. Germany Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 44. France Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 45. UK Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 46. Russia Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 47. Italy Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 48. Australia Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 49. Benelux Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 50. Nordic Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 51. MENA Drugs of Bioengineered Protein Value Market Share by Country in 2019
Figure 52. Saudi Arabia Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 53. UAE Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 54. Turkey Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 55. South Africa Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Figure 56. Egypt Drugs of Bioengineered Protein Market Size YoY Growth, 2015-2025 ($ millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets